Integrated DNA Technologies Acquires Synthegen
News Feb 02, 2006
Illustrating its commitment to continued growth, this latest acquisition by Coralville, Iowa based IDT further expands the company’s expertise in the synthesis of modified oligonucleotides.
The acquisition of Synthegen follows IDT’s recent purchase of San Diego, CA based GenBase, Inc. and the opening of the company’s first satellite production center.
"Synthegen has developed significant skills and abilities that target the specialty oligo market," said Integrated DNA Technologies, Inc. COO Trey Martin.
"This acquisition allows us to merge that expertise with IDT’s industry-leading quality and QC systems."
"It also brings the Synthegen product range to a wider market, and ensures that our customers continue to benefit from the widest selection, highest service level, and most reliable and consistent delivery of custom oligos available anywhere."
"Our success over the last 10 years clearly played a central role in the development of this deal," said David Colvin, president of Synthegen.
"And as our customer segment is smaller and more specialized than IDT’s, we were delighted to discover that they share our belief that the customer is the most important part of what we do."
"We know that the needs of our clients will be well served, and that this deal will deliver significant benefits for them."
Colvin is working with Integrated DNA Technologies, Inc. to support the seamless transition of the Synthegen product line into IDT’s portfolio.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE